دورية أكاديمية

Effect of Amnioinfusion on Outcome of Neonates Born With Meconium Stained Amniotic Fluid.

التفاصيل البيبلوغرافية
العنوان: Effect of Amnioinfusion on Outcome of Neonates Born With Meconium Stained Amniotic Fluid.
المؤلفون: Thakkar, Pareshkumar A., Aiyer, Sheila
المصدر: National Journal of Integrated Research in Medicine; 2012, Vol. 3 Issue 2, p86-90, 5p
مصطلحات موضوعية: AMNIOINFUSIONS, NEWBORN infant development, MECONIUM, AMNIOTIC liquid, SEPTICEMIA in children
مصطلحات جغرافية: VADODARA (India), GUJARAT (India)
مستخلص: Background & Objective: Meconium stained amniotic fluid (MSAF) is associated with significant morbidity and mortality. Amnioinfusion can decrease complications of MSAF. The objective was to study role of Amnioinfusion on outcome of babies born with MSAF. Methods: Design: Prospective Interventional Study Setting: Medical college and SSG Hospital, Baroda, Gujarat. Study Period: from 1st March 2003 to 31st December 2003 Inclusion criteria: evidence of Thick MSAF AND station of the head is zero or above. Patients were grouped randomly in to two groups. In Group A amnioinfusion was performed while in Group B amnioinfusion was not done. Amnioinfusion was done by inserting foley catheter transcervically and infusing normal saline or ringer lactate at the rate of 100ml/min till the coming liquor became clear. Outcome was studied. Results: Out of total 227 babies with thick MSAF amnioinfusion was performed in 52 patients (Group A), rest 175 patients were controls (Group B). Incidence of MAS was significantly lower 7.7% in Group A compared to 25.7% of Group B (P < 0.005). There was significantly lower incidence of birth asphyxia 1.92% in Group A compared to 34.8% in Group B (P value < 0.0001). Incidence of HIE was significantly lower in group A. Incidence of Air leaks and PPHN was similar in both groups. Rate of NICU admission was significantly lower in group A (13.4%) compared to group (51.4%), P value < 0.001. Mortality in Group A was much lower 5.8% compared to 14.85% in Group B (p =0.08). Amnioinfusion did not increase risk of maternal or neonatal sepsis. Conclusion: Amnioinfusion significantly decreases complications of MSAF and improves perinatal survival. [ABSTRACT FROM AUTHOR]
Copyright of National Journal of Integrated Research in Medicine is the property of Academy for Continuing Medical Education and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index